Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T)
<h4>Aims</h4> <p>Hypoglycaemia is a significant risk in insulin treated type 2 diabetes and has been associated with future risk of cardiovascular events. We compared the frequency of low-glucose events using continuous glucose monitoring (CGM) with that of self-reported hypoglyce...
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Journal article |
| Argitaratua: |
Elsevier
2017
|